Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy

Tools

Item Type:	Article
Title:	Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy
Creators Name:	Klein, J., Gonzalez, J., Duchene, J., Esposito, L., Pradere, J.P., Neau, E., Delage, C., Calise, D., Ahluwalia, A., Carayon, P., Pesquero, J.B., Bader, M., Schanstra, J.P. and Bascands, J.L.
Abstract:	Renal fibrosis is the common histological feature of advanced glomerular and tubulointerstitial disease leading to end-stage renal disease (ESRD). However, specific antifibrotic therapies to slow down the evolution to ESRD are still absent. Because persistent inflammation is a key event in the development of fibrosis, we hypothesized that the proinflammatory kinin B1 receptor (B1R) could be such a new target. Here we show that, in the unilateral ureteral obstruction model of renal fibrosis, the B1R is overexpressed and that delayed treatment with an orally active nonpeptide B1R antagonist blocks macrophage infiltration, leading to a reversal of the level of renal fibrosis. In vivo bone marrow transplantation studies as well as in vitro studies on renal cells show that part of this antifibrotic mechanism of B1R blockade involves a direct effect on resident renal cells by inhibiting chemokine CCL2 and CCL7 expression. These findings suggest that blocking the B1R is a promising antifibrotic therapy.
Keywords:	Kidney Disease, Bradykinin, Unilateral Ureteral Obstruction, Chemokine, Reversion, Animals, Mice
Source:	FASEB Journal
ISSN:	0892-6638
Publisher:	Federation of American Societies for Experimental Biology
Volume:	23
Number:	1
Page Range:	134-142
Date:	January 2009
Official Publication:	https://doi.org/10.1096/fj.08-115600
PubMed:	View item in PubMed

Repository Staff Only: item control page